Araştırma Makalesi
BibTex RIS Kaynak Göster

Leukemia immunophenotyping

Yıl 1992, Cilt: 5 Sayı: 4, 165 - 176, 01.12.1992

Öz

Immunophenotyping is, by definition, to classify and subclassify the cells by using monoclonal antibodies (Mabs) raised against cell surface antigens. These antigens may be helpful to discriminate morphologically indistinguishable cells. Immunophenotyping has been used in clinical practice for many years and it became an indispensable diagnostic aid for certain diseases.

Kaynakça

  • Qreaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 1981; 41: 4752 - 4766.
Yıl 1992, Cilt: 5 Sayı: 4, 165 - 176, 01.12.1992

Öz

Kaynakça

  • Qreaves MF. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res 1981; 41: 4752 - 4766.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Konular Klinik Tıp Bilimleri
Bölüm Reviews
Yazarlar

M. Bagaran Bu kişi benim

Yayımlanma Tarihi 1 Aralık 1992
Yayımlandığı Sayı Yıl 1992 Cilt: 5 Sayı: 4

Kaynak Göster

APA Bagaran, M. (1992). Leukemia immunophenotyping. Marmara Medical Journal, 5(4), 165-176.
AMA Bagaran M. Leukemia immunophenotyping. Marmara Med J. Aralık 1992;5(4):165-176.
Chicago Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal 5, sy. 4 (Aralık 1992): 165-76.
EndNote Bagaran M (01 Aralık 1992) Leukemia immunophenotyping. Marmara Medical Journal 5 4 165–176.
IEEE M. Bagaran, “Leukemia immunophenotyping”, Marmara Med J, c. 5, sy. 4, ss. 165–176, 1992.
ISNAD Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal 5/4 (Aralık 1992), 165-176.
JAMA Bagaran M. Leukemia immunophenotyping. Marmara Med J. 1992;5:165–176.
MLA Bagaran, M. “Leukemia Immunophenotyping”. Marmara Medical Journal, c. 5, sy. 4, 1992, ss. 165-76.
Vancouver Bagaran M. Leukemia immunophenotyping. Marmara Med J. 1992;5(4):165-76.